Acute promyelocytic leukemia

Peter H. Wiernik; Robert E. Gallagher; Martin S. Tallman

doi:10.1007/978-3-319-64263-5_21

Acute promyelocytic leukemia

Peter H. Wiernik^*, Robert E. Gallagher, Martin S. Tallman

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

Original language	English (US)
Title of host publication	Neoplastic Diseases of the Blood
Publisher	Springer International Publishing
Pages	409-463
Number of pages	55
ISBN (Electronic)	9783319642635
ISBN (Print)	9783319642628
DOIs	https://doi.org/10.1007/978-3-319-64263-5_21
State	Published - Jan 1 2018

Keywords

All-trans retinoic acid
Arsenic trioxide
Pseudotumor cerebri
Translocation 15;17

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-64263-5_21

Cite this

@inbook{070d267832b84860a597018c32677680,

title = "Acute promyelocytic leukemia",

abstract = "Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.",

keywords = "All-trans retinoic acid, Arsenic trioxide, Pseudotumor cerebri, Translocation 15;17",

author = "Wiernik, {Peter H.} and Gallagher, {Robert E.} and Tallman, {Martin S.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG 2018.",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-3-319-64263-5_21",

language = "English (US)",

isbn = "9783319642628",

pages = "409--463",

booktitle = "Neoplastic Diseases of the Blood",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Acute promyelocytic leukemia

AU - Wiernik, Peter H.

AU - Gallagher, Robert E.

AU - Tallman, Martin S.

N1 - Publisher Copyright: © Springer International Publishing AG 2018.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

AB - Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

KW - All-trans retinoic acid

KW - Arsenic trioxide

KW - Pseudotumor cerebri

KW - Translocation 15;17

UR - http://www.scopus.com/inward/record.url?scp=85047036713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047036713&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-64263-5_21

DO - 10.1007/978-3-319-64263-5_21

M3 - Chapter

AN - SCOPUS:85047036713

SN - 9783319642628

SP - 409

EP - 463

BT - Neoplastic Diseases of the Blood

PB - Springer International Publishing

ER -

Acute promyelocytic leukemia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this